Tier 3 · Filer Universe
Gain Therapeutics, Inc.
GANX · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$1.71
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001819411
Liquidity rank
#4064
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | -0.61 | 2025-12-31 | 0001104659-26-035188 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.13 | 2026-03-31 | 0001104659-26-058649 |
SEC EDGAR Frames batch generated 2026-07-16T23:27:27.057Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerTMO · Tier 1 peerDHR · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames